Splenic vein thrombosis epidemiology and demographics: Difference between revisions
| (5 intermediate revisions by 2 users not shown) | |||
| Line 3: | Line 3: | ||
{{CMG}} ; {{AE}} {{Vbe}} | {{CMG}} ; {{AE}} {{Vbe}} | ||
==Overview== | ==Overview== | ||
The [[incidence]] of [[splenic vein thrombosis]] was estimated to be 14,100 cases per 100,000 individuals worldwide. Splenic vein thrombosis affects men and women equally. There is no racial predilection for splenic vein thrombosis. | |||
== Epidemiology and demographics== | == Epidemiology and demographics== | ||
The incidence of | The [[incidence]] of [[splenic vein thrombosis]] was estimated to be 14,100 cases per 100,000 individuals worldwide.<ref name="pmid25133039">{{cite journal| author=Badillo R, Francis D| title=Diagnosis and treatment of gastroesophageal reflux disease. | journal=World J Gastrointest Pharmacol Ther | year= 2014 | volume= 5 | issue= 3 | pages= 105-12 | pmid=25133039 | doi=10.4292/wjgpt.v5.i3.105 | pmc=4133436 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=25133039 }}</ref><ref name="pmid29211374">{{cite journal| author=Gouin B, Robert-Ebadi H, Casini A, Beauverd Y, Fontana P, Righini M et al.| title=[Splanchnic vein thrombosis]. | journal=Rev Med Suisse | year= 2017 | volume= 13 | issue= 586 | pages= 2138-2143 | pmid=29211374 | doi= | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=29211374 }}</ref> | ||
== Age== | == Age== | ||
Splenic vein thrombosis affects men and women equally | [[Splenic vein thrombosis]] affects [[men]] and [[Women's College Hospital|women]] equally | ||
==Race== | ==Race== | ||
There is no racial predilection for splenic vein thrombosis | There is no racial predilection for [[splenic vein thrombosis]] | ||
==References== | ==References== | ||
{{reflist|2}} | {{reflist|2}} | ||
Latest revision as of 14:37, 1 March 2018
|
Splenic vein thrombosis Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Splenic vein thrombosis epidemiology and demographics On the Web |
|
American Roentgen Ray Society Images of Splenic vein thrombosis epidemiology and demographics |
|
FDA on Splenic vein thrombosis epidemiology and demographics |
|
CDC on Splenic vein thrombosis epidemiology and demographics |
|
Splenic vein thrombosis epidemiology and demographics in the news |
|
Blogs on Splenic vein thrombosis epidemiology and demographics |
|
Risk calculators and risk factors for Splenic vein thrombosis epidemiology and demographics |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] ; Associate Editor(s)-in-Chief: Vindhya BellamKonda, M.B.B.S [2]
Overview
The incidence of splenic vein thrombosis was estimated to be 14,100 cases per 100,000 individuals worldwide. Splenic vein thrombosis affects men and women equally. There is no racial predilection for splenic vein thrombosis.
Epidemiology and demographics
The incidence of splenic vein thrombosis was estimated to be 14,100 cases per 100,000 individuals worldwide.[1][2]
Age
Splenic vein thrombosis affects men and women equally
Race
There is no racial predilection for splenic vein thrombosis
References
- ↑ Badillo R, Francis D (2014). "Diagnosis and treatment of gastroesophageal reflux disease". World J Gastrointest Pharmacol Ther. 5 (3): 105–12. doi:10.4292/wjgpt.v5.i3.105. PMC 4133436. PMID 25133039.
- ↑ Gouin B, Robert-Ebadi H, Casini A, Beauverd Y, Fontana P, Righini M; et al. (2017). "[Splanchnic vein thrombosis]". Rev Med Suisse. 13 (586): 2138–2143. PMID 29211374.